Cellweaverse Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$4.33M
- Investors
-
11
Cellweaverse General Information
Description
Developer of cell culture-based biomaterials designed for the production of animal-derived materials without animal harvesting. The company's platform utilizes proprietary cell line development and cultivation technologies to produce biomaterials for biomedical, pharmaceutical, cosmetic, food, and industrial applications, including endotoxin testing materials and alternative biological raw materials, enabling biotechnology, healthcare, and manufacturing organizations to access animal-derived biomaterials through controlled cell-based production methods.
Contact Information
Website
www.cellweaverse.comCorporate Office
- 6th Floor, 87 Cheongam-ro
- Room 638-7, Nam-gu, Jigok-dong, Changeup Ground
- Pohang, Gyeonggi-do
- South Korea
Corporate Office
- 6th Floor, 87 Cheongam-ro
- Room 638-7, Nam-gu, Jigok-dong, Changeup Ground
- Pohang, Gyeonggi-do
- South Korea
Cellweaverse Timeline
Cellweaverse Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC | 09-Sep-2026 | $4.33M | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | 22-Dec-2025 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 07-Apr-2025 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Nov-2024 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Nov-2024 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cellweaverse Patents
Cellweaverse Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026054241-A1 | Deodorant composition for removing senile odor comprising magnoliae flos extract or fraction | Pending | 03-Sep-2024 |
Cellweaverse Signals
Cellweaverse Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CKD Venture Capital | Corporate Venture Capital | Minority | ||
| Industrial Bank of Korea | PE/Buyout | Minority | ||
| Korea Technology Finance | Government | Minority | ||
| Mirae Asset Venture Investment | Venture Capital | Minority | ||
| Posco Investment | Corporate Venture Capital | Minority |
Cellweaverse FAQs
-
When was Cellweaverse founded?
Cellweaverse was founded in 2024.
-
Where is Cellweaverse headquartered?
Cellweaverse is headquartered in Pohang, South Korea.
-
What is the size of Cellweaverse?
Cellweaverse has 9 total employees.
-
What industry is Cellweaverse in?
Cellweaverse’s primary industry is Biotechnology.
-
Is Cellweaverse a private or public company?
Cellweaverse is a Private company.
-
What is Cellweaverse’s current revenue?
The current revenue for Cellweaverse is .
-
How much funding has Cellweaverse raised over time?
Cellweaverse has raised $4.33M.
-
Who are Cellweaverse’s investors?
CKD Venture Capital, Industrial Bank of Korea, Korea Technology Finance, Mirae Asset Venture Investment, and Posco Investment are 5 of 11 investors who have invested in Cellweaverse.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process